Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren vs. Hydrochlorothiazide in Hypertensive Type 2 Diabetes
NCT01480791Phase 2Withdrawn
- Sponsor
- Jewish General Hospital
- Start
- Jan 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aliskiren in hypertension (HTN), sponsored by Jewish General Hospital. Planned start Jan 2012; status: withdrawn.
02
Drugs
aliskiren
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01480791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01480791.